Page last updated: 2024-10-19

phosphorylcholine and Influenza, Human

phosphorylcholine has been researched along with Influenza, Human in 2 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research Excerpts

ExcerptRelevanceReference
"Liposomal influenza vaccines are a promising strategy to overcome these limitations and the use of liposomal immune modulators and intranasal administration of liposomal influenza vaccines may be a means by which to improve influenza protection."1.72Enhanced Influenza Immunity by Nasal Mucosal Administration of the TPGS-Modified Liposomal Vaccine. ( Gao, T; Ma, S; Mai, Y; Yang, J; Yu, N; Yu, R, 2022)
"Severe influenza diseases with high mortality have been frequently reported, especially in those patients infected with avian influenza A (H5N1, H7N9 or H10N8) or during a pandemic."1.46C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases. ( Bai, T; Bo, H; Gao, R; Shu, Y; Wang, L; Zhang, Y, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ma, S1
Yu, R1
Mai, Y1
Yu, N1
Gao, T1
Yang, J1
Gao, R1
Wang, L1
Bai, T1
Zhang, Y1
Bo, H1
Shu, Y1

Other Studies

2 other studies available for phosphorylcholine and Influenza, Human

ArticleYear
Enhanced Influenza Immunity by Nasal Mucosal Administration of the TPGS-Modified Liposomal Vaccine.
    AAPS PharmSciTech, 2022, Sep-30, Volume: 23, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Intranasal; alpha-Tocopherol; Animals; Antibodies, Viral; Hu

2022
C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.
    EBioMedicine, 2017, Volume: 22

    Topics: Adolescent; Adult; Animals; C-Reactive Protein; Cell Line; Child; Child, Preschool; Complement Activ

2017